Truist Financial Cuts Humana (NYSE:HUM) Price Target to $200.00

Humana (NYSE:HUM) had its target price lowered by Truist Financial from $285.00 to $200.00 in a research note issued to investors on Tuesday morning, Marketbeat reports. The brokerage currently has a hold rating on the insurance provider’s stock.

Several other equities research analysts also recently issued reports on the company. Cantor Fitzgerald dropped their target price on Humana from $290.00 to $201.00 and set a “neutral” rating on the stock in a research report on Thursday, February 12th. Sanford C. Bernstein reiterated an “outperform” rating and set a $344.00 price objective on shares of Humana in a research note on Tuesday, January 6th. Barclays restated an “underperformer” rating on shares of Humana in a research note on Monday, January 5th. Royal Bank Of Canada lowered Humana from an “outperform” rating to a “sector perform” rating and reduced their target price for the company from $322.00 to $189.00 in a report on Thursday, February 12th. Finally, Oppenheimer set a $250.00 price target on Humana in a research report on Thursday, February 12th. Seven equities research analysts have rated the stock with a Buy rating, fifteen have given a Hold rating and four have given a Sell rating to the company. According to data from MarketBeat.com, Humana presently has an average rating of “Hold” and a consensus price target of $228.48.

Humana Trading Up 1.9%

NYSE:HUM opened at $190.61 on Tuesday. Humana has a 12 month low of $169.61 and a 12 month high of $315.35. The company has a current ratio of 2.00, a quick ratio of 2.02 and a debt-to-equity ratio of 0.70. The firm’s 50 day moving average is $239.01 and its 200 day moving average is $259.13. The stock has a market capitalization of $22.92 billion, a PE ratio of 19.41, a price-to-earnings-growth ratio of 2.00 and a beta of 0.44.

Humana (NYSE:HUM) last issued its earnings results on Wednesday, February 11th. The insurance provider reported ($3.96) earnings per share (EPS) for the quarter, beating the consensus estimate of ($4.01) by $0.05. The firm had revenue of $32.64 billion for the quarter, compared to analyst estimates of $32.08 billion. Humana had a return on equity of 11.43% and a net margin of 0.92%.The business’s revenue was up 11.3% on a year-over-year basis. During the same period in the previous year, the company posted ($2.16) earnings per share. Humana has set its FY 2026 guidance at 9.000-9.000 EPS. Sell-side analysts expect that Humana will post 16.47 earnings per share for the current year.

Humana Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, April 24th. Stockholders of record on Friday, March 27th will be given a dividend of $0.885 per share. The ex-dividend date is Friday, March 27th. This represents a $3.54 annualized dividend and a dividend yield of 1.9%. Humana’s dividend payout ratio (DPR) is 36.05%.

Institutional Inflows and Outflows

Institutional investors have recently added to or reduced their stakes in the company. Montag A & Associates Inc. increased its position in shares of Humana by 1,880.0% during the 4th quarter. Montag A & Associates Inc. now owns 99 shares of the insurance provider’s stock valued at $25,000 after purchasing an additional 94 shares during the last quarter. CoreCap Advisors LLC boosted its stake in Humana by 54.4% in the fourth quarter. CoreCap Advisors LLC now owns 105 shares of the insurance provider’s stock worth $27,000 after buying an additional 37 shares in the last quarter. Fideuram Asset Management Ireland dac purchased a new position in shares of Humana during the fourth quarter worth approximately $27,000. Rosenberg Matthew Hamilton lifted its holdings in shares of Humana by 136.0% in the 4th quarter. Rosenberg Matthew Hamilton now owns 118 shares of the insurance provider’s stock worth $30,000 after acquiring an additional 68 shares during the last quarter. Finally, Elevation Point Wealth Partners LLC bought a new stake in shares of Humana in the 2nd quarter worth approximately $32,000. Institutional investors own 92.38% of the company’s stock.

About Humana

Humana Inc (NYSE: HUM) is a health insurance company headquartered in Louisville, Kentucky, that primarily serves individuals and groups across the United States. The company is best known for its Medicare business, offering Medicare Advantage plans and prescription drug (Part D) coverage, alongside a range of commercial and employer-sponsored group health plans. Humana’s products are designed to cover medical, behavioral health and pharmacy needs for members, with particular emphasis on seniors and Medicare-eligible populations.

In addition to traditional insurance products, Humana provides care-management and wellness services intended to support chronic-condition management, preventive care and care coordination.